SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

The Trade Desk, Inc. engages in the provision of a self-service and cloud-based ad-buying platform. The firm operates through the following geographical segments: United States and International. It offers omnichannel advertising, audience targeting, solutions for identity, application programming interface (API), custom, and programmatic, measurement and optimization. The company was founded by Jeffrey Terry Green and David Pickles in November 2009 and is headquartered in Ventura, CA.

Trade Desk Inc - Ordinary Shares - Class A

Trade Desk Inc

Trade Desks prolonged slide to multiyear lows is being tied to worries about softer ad spending and slowing growth, alongside competition from Amazon and other automated advertising platforms; claims about Apple/Safari blocking its ads remain disputed. Traders are sharply divided, with many criticizing CEO Jeff Green and his proposed compensation while bullish voices point to the companys cash generation and see the selloff as potentially overdone.

Micron Technology, Inc. engages in the provision of innovative memory and storage solutions. It operates through the following segments: Cloud Memory Business Unit (CMBU), Core Data Center Business Unit (CDBU), Mobile and Client Business Unit (MCBU), and Automotive and Embedded Business Unit (AEBU). The CMBU segment focuses on memory solutions for large hyperscale cloud customers and High-Bandwidth Memory for all data center customers. The CDBU segment is involved in memory solutions for mid-tier cloud, enterprise, and OEM data center customers and storage solutions for all data center customers. The MCBU segment focuses on memory and storage solutions for the mobile and client segments. The AEBU segment is involved in memory and storage solutions for the automotive, industrial, and consumer segments. The company was founded by Ward D. Parkinson, Joseph Leon Parkinson, Dennis Wilson, and Doug Pitman on October 5, 1978 and is headquartered in Boise, ID.

Micron Technology Inc.

Micron Technology Inc

Microns upcoming fiscal Q4 earnings and forward outlook are the dominant focus, with traders watching whether tight AI-driven DRAM, NAND and HBM supply can sustain pricing and growth. Many expect strong results, while others warn that optimism may already be priced in and debate the risk of a post-earnings selloff or a shorter-than-expected memory cycle.

Advisorshares Trust - AdvisorShares Pure US Cannabis ETF

AdvisorShares Pure US Cannabis ETF

A GAO report identifying gaps in federal drug-scheduling procedures has prompted the cannabis rescheduling hearing to pause while the administrative judge considers whether to add the report to the record. Traders are divided between viewing this as a temporary procedural delay and fearing it could prolong or complicate the path to Schedule III; many see the selloff as an overreaction and are buying the dip.

GameStop Corp. engages in offering games and entertainment products through its ecommerce properties and stores. The firm’s stores and ecommerce sites operate primarily under the names GameStop, EB Games, and Micromania. It operates through the following geographical segments: United States, Canada, Australia, and Europe. The company was founded by Daniel A. DeMatteo in 1996 and is headquartered in Grapevine, TX.

Gamestop Corporation - Ordinary Shares - Class A

GameStop Corp

Ryan Cohens reported purchases of GameStop shares are driving attention, with bullish traders treating them as a confidence signal and speculating about a short squeeze or warrant-related move. Others argue insider buying alone is not enough without substantive company news, and point to fading momentum and resistance around recent levels.

Iovance Biotherapeutics, Inc. engages in the development and commercialization of cell therapies using autologous tumor-infiltrating lymphocytes (TIL) for the treatment of cancer. Its products include Amtagvi (lifileucel), and Proleukin (aldesleukin). The firm also develops investigational TIL therapies for other solid tumor cancers. The company was founded by Robert T. Brooke on September 17, 2007 and is headquartered in San Carlos, CA.

Iovance Biotherapeutics Inc

Iovances shares surged after the company raised its full-year revenue outlook, citing stronger demand for Amtagvi and Proleukin. Traders largely welcomed the sales growth and discussed possible short covering, while others cautioned about the sharp run-up and potential dilution; upcoming cancer-treatment data also featured in the bullish outlook.

Fair Isaac Corp. engages in the provision of decision management solutions. It operates through the Software and Scores segments. The Software segment includes pre-configured analytic and decision management solutions designed for a specific type of business need or process. The Scores segment focuses on business-to-business scoring solutions and services, business-to-consumer scoring solutions and services including myFICO solutions for consumers and associated professional services. The company was founded by Bill Fair and Earl Isaac in 1956 and is headquartered in San Jose, CA.

Fair Isaac Corp.

Fair, Isaac Corp.

The FHFAs move to include VantageScore alongside FICO in Fannie Mae and Freddie Mac mortgage pricing has raised concerns that competition could erode FICOs long-standing mortgage-scoring advantage and pricing power, driving a sharp selloff. Traders are split between viewing the decline as a fundamental repricing of the business and looking for an oversold relief bounce.

Trulieve Cannabis Corp. engages in the cultivation, processing, manufacturing, and retail distribution of medical and adult-use cannabis products. It cultivates and produces its products in-house and distributes to its branded stores, as well as directly to patients via home delivery. The company was founded by Kim Rivers & Jason Pernell on September 17, 1940 and is headquartered in Tallahassee, FL.

Trulieve Cannabis Corp - Ordinary Shares (Sub Voting)

Trulieve Cannabis Corp 

A pause in the DEA cannabis-rescheduling hearing is driving discussion, with traders focused on a judges request for the agency to respond on whether the record should be reopened to include a GAO report. Some view the resulting delay as limited and remain optimistic about Schedule III rescheduling, while others are frustrated by the uncertain timeline.

Armada Acquisition Corp. II is a blank check company, which engages in the purpose of effecting a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization or other similar business combinations with one or more businesses. The company was founded on October 3, 2024 and is headquartered in Miami, FL.

Armada Acquisition Corp. II - Ordinary Shares- Class A

Evernorth Holdings Inc.

Evernorths transition from the Armada SPAC to trading as XRPN is driving attention, with the companys planned XRP treasury strategy seen by bullish traders as a way to gain exposure to XRP through a Nasdaq-listed stock. Enthusiasm around the ticker change and warrants is balanced by questions about valuation, thin trading activity, and the risks of the SPAC transition.

DraftKings, Inc. is a digital sports entertainment and gaming company, which engages in the provision of online sports betting, online casino, daily fantasy sports product offerings, DraftKings Marketplace, retail sportsbook, media, and other consumer product offerings. The company was founded by Jason D. Robins, Matthew Kalish, and Paul Liberman on December 31, 2011 and is headquartered in Boston, MA.

DraftKings Inc. - Ordinary Shares - Class A

DraftKings Inc

DraftKings is under pressure amid concerns that Kalshi and Polymarket are competing for sportsbook customers, alongside uncertainty over how prediction markets will be regulated. Bears worry that competition and investment spending will weigh on margins, while bulls point to growth in DraftKings own prediction-market product and sportsbook business as reasons the company could benefit under either regulatory outcome.

Summit Therapeutics, Inc. is a biopharmaceutical company, that focuses on the discovery, development, and commercialization of patient, physician, caregiver, and societal-friendly medicinal therapies intended to improve quality of life, increase potential duration of life, and resolve serious unmet medical needs. The firm conducts clinical programs focusing on Clostridioides Difficile Infection (CDI). Its lead product, Ridinilazole, is an orally administered small molecule antibiotic that is in Phase III clinical trials for the treatment of CDI. The company was founded in 2003 and is headquartered in Miami, FL.

Summit Therapeutics Inc

AstraZenecas strategic investment in Summit and clinical collaboration on ivonescimab combinations are driving attention, with many traders viewing the deal as validation of the cancer drug and relief for Summits funding needs. Others caution that the equity investment is dilutive and not a buyout, while the separate FDA decision on ivonescimab remains uncertain.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

🟢 $RIOT 25C Jan 15 
 
💰 $1,100,000 premium 
💵 $4.8/contract 
📊 2.2x Vol/OI 
📍 Spot $24.74 
 
💰 Large premium | 🚨 Repeat sweep 
 
🌊 Dark Flow | Options Flow

StockTwits Web

Riot Platforms Inc

 25C Jan 15 
 
💰 $1,100,000 premium 
💵 $4.8/contract 
📊 2.2x Vol/OI 
📍 Spot $24.74 
 
💰 Large premium | 🚨 Repeat sweep 
 
🌊 Dark Flow | Options Flow